Investor Stock List
Ranked #7,854 of 8,699 institutional investors

Ishara Investments LP

Los Angeles, CA

$113M
US stock portfolio at live prices · today −$1.5M (−1.30%)
Live prices, last trade 11:44 AM ET
Value at quarter end (Q3 2026)
$120M
Change from Q2 2026
−$14.8M (−11.00%)
Positions
38 · 13 new, 13 sold out
Filed
Nov 16, 2026

Not counted in the ranking: put options on $1.5M. $5.5M of holdings we could not match to a US listing are included at their reported quarter-end value.

Holdings

Q3 2026 13F, live prices
BBIO 6.84%TVTX 6.23%XERS 5.90%CYTK 5.87%ACAD 4.95%
StockSharesValue, live% of portfoliovs Q2 2026
BBIO BridgeBio Pharma, Inc.100,000$7.7M6.84%Added +74%
TVTX Travere Therapeutics, Inc.145,000$7.0M6.23%Added +77%
XERS Xeris Biopharma Holdings, Inc.400,000$6.7M5.90%Reduced −67%
CYTK Cytokinetics, Incorporated128,000$6.6M5.87%Added +290%
ACAD Acadia Pharmaceuticals Inc.320,000$5.6M4.95%Reduced −22%
TARS Tarsus Pharmaceuticals, Inc.70,000$5.2M4.64%New
PRAX Praxis Precision Medicines, Inc.17,000$5.2M4.61%Reduced −25%
ARQT Arcutis Biotherapeutics, Inc.180,000$4.8M4.27%New
PTCT PTC Therapeutics, Inc.80,000$4.6M4.09%New
VRDN Viridian Therapeutics, Inc.150,000$4.6M4.08%New
UTHR United Therapeutics Corporation8,000$4.4M3.94%New
VERA Vera Therapeutics, Inc.150,000$3.9M3.42%Added +1,363%
ANNX Annexon, Inc.1,120,000$3.5M3.13%Added +37%
SLN Silence Therapeutics plc160,000$3.2M2.80%Added +189%
BIIB Biogen Inc.12,000$3.0M2.65%New
BMRN BioMarin Pharmaceutical Inc.48,000$2.9M2.59%Reduced −67%
RARE Ultragenyx Pharmaceutical Inc.160,000$2.7M2.36%Reduced −22%
CELC Celcuity Inc.48,000$2.6M2.32%New
DBVT DBV Technologies S.A.270,000$2.5M2.19%Added +46%
LGND Ligand Pharmaceuticals Incorporated8,000$2.3M2.04%New
PCVX Vaxcyte, Inc.40,000$2.3M2.01%Reduced −51%
GMAB Genmab A/S40,000$2.0M1.81%Reduced −61%
ZNTL Zentalis Pharmaceuticals, Inc.1,080,000$1.5M1.34%Added +5%
BEAM Beam Therapeutics Inc.70,000$1.5M1.33%Added +71%
MLYS Mineralys Therapeutics, Inc.100,000$1.4M1.24%Reduced −2%
AXSM Axsome Therapeutics, Inc.10,000$1.3M1.16%Reduced −39%
NBIX Neurocrine Biosciences, Inc.8,000$1.2M1.09%New
ORIC ORIC Pharmaceuticals, Inc.160,000$1.2M1.06%Added +30%
CTNM Contineum Therapeutics, Inc.108,000$957K0.85%Reduced −47%
MLTX MoonLake Immunotherapeutics80,000$891K0.79%New
MNPR Monopar Therapeutics Inc.12,000$821K0.73%Reduced −2%
SPRY ARS Pharmaceuticals, Inc.200,000$633K0.56%Added +39%
OLMA Olema Oncology, Inc.80,000$570K0.50%New
LXRX Lexicon Pharmaceuticals, Inc.320,000$522K0.46%Reduced −75%
IONS Ionis Pharmaceuticals, Inc.16,000$441K0.39%New
WVE Wave Life Sciences, Inc.160,000$428K0.38%Reduced −51%
SVRA Savara Inc.80,000$340K0.30%New
GOSS Gossamer Bio, Inc.24,000$270K0.24%Added +134%

Sold out in Q3 2026

StockShares held at Q2 2026Worth today
INSM Insmed Incorporated51,250$7.5M
AGIO Agios Pharmaceuticals, Inc.164,000$4.7M
KURA Kura Oncology, Inc.276,750$2.0M
SRRK Scholar Rock Holding Corporation30,750$1.6M
ELVN Enliven Therapeutics, Inc.32,800$1.5M
NUVB Nuvation Bio Inc.369,000$1.4M
VRTX Vertex Pharmaceuticals Incorporated2,460$1.3M
NKTR Nektar Therapeutics26,650$839K
TNXP Tonix Pharmaceuticals Holding Corp.338,250$829K
ALNY Alnylam Pharmaceuticals, Inc.5,125$771K
ERAS Erasca, Inc.41,000$579K
MREO Mereo BioPharma Group plc768,750$205K
SION Sionna Therapeutics, Inc.30,701$88K